Department of Physiology, Faculty of Medicine, Srinakharinwirot University, Sukhumvit 23, Wattana, Bangkok 10110, Thailand.
Am J Physiol Gastrointest Liver Physiol. 2012 May 15;302(10):G1199-206. doi: 10.1152/ajpgi.00143.2011. Epub 2012 Mar 8.
The effect of prolactin (PRL) on ion transport across the rat colon epithelium was investigated using Ussing chamber technique. PRL (1 μg/ml) induced a sustained decrease in short-circuit current (I(sc)) in the distal colon with an EC(50) value of 100 ng/ml and increased I(sc) in the proximal colon with an EC(50) value of 49 ng/ml. In the distal colon, the PRL-induced decrease in I(sc) was not affected by Na(+) channel blocker amiloride or Cl(-) channel blockers, NPPB, DPC, or DIDS, added mucosally. However, the response was inhibited by mucosal application of K(+) channel blockers glibenclamide, quinidine, and chromanol 293B, whereas other K(+) channel blockers, Ba(2+), tetraethylammonium, clotrimazole, and apamin, failed to have effects. The PRL-induced decrease in I(sc) was also inhibited by Na(+)-K(+)-2Cl(-) transporter inhibitor bumetanide, Ba(2+), and chromanol 293B applied serosally. In the transverse and proximal colon, the PRL-induced increase in I(sc) was suppressed by DPC, glibenclamide, and bumetanide, but not by NPPB, DIDS, or amiloride. The PRL-induced changes in I(sc) in both distal and proximal colon were abolished by JAK2 inhibitor AG490, but not BAPTA-AM, the Ca(2+) chelating agent, or phosphatidylinositol 3-kinase inhibitor wortmannin. These results suggest a segment-specific effect of PRL in rat colon, by activation of K(+) secretion in the distal colon and activation of Cl(-) secretion in the transverse and proximal colon. Both PRL actions are mediated by JAK-STAT-dependent pathway, but not phosphatidylinositol 3-kinase pathway or Ca(2+) mobilization. These findings suggest a role of PRL in the regulation of electrolyte transport in mammalian colon.
采用 Ussing 腔技术研究了催乳素(PRL)对大鼠结肠上皮离子转运的影响。PRL(1μg/ml)诱导远端结肠短电路电流(Isc)持续下降,EC50 值为 100ng/ml,并增加近端结肠 Isc,EC50 值为 49ng/ml。在远端结肠中,PRL 诱导的 Isc 下降不受 Na+通道阻滞剂阿米洛利或 Cl-通道阻滞剂 NPPB、DPC 或 DIDS 的影响,这些药物均施加于黏膜侧。然而,该反应被黏膜应用 K+通道阻滞剂格列本脲、奎尼丁和 chromanol 293B 所抑制,而其他 K+通道阻滞剂 Ba2+、四乙铵、克霉唑和阿帕米则没有作用。PRL 诱导的 Isc 下降也被 Na+-K+-2Cl-转运体抑制剂布美他尼、Ba2+和 chromanol 293B 施加于浆膜侧所抑制。在横结肠和近端结肠中,PRL 诱导的 Isc 增加被 DPC、格列本脲和布美他尼抑制,但不受 NPPB、DIDS 或阿米洛利的抑制。JAK2 抑制剂 AG490 可消除 PRL 在远端和近端结肠引起的 Isc 变化,但 BAPTA-AM、钙螯合剂或磷脂酰肌醇 3-激酶抑制剂wortmannin 则不能消除这些变化。这些结果表明 PRL 在大鼠结肠中具有节段特异性作用,通过激活远端结肠的 K+分泌和激活横结肠和近端结肠的 Cl-分泌。PRL 的这两种作用均由 JAK-STAT 依赖性途径介导,而不是磷脂酰肌醇 3-激酶途径或 Ca2+动员。这些发现表明 PRL 在调节哺乳动物结肠中的电解质转运中起作用。